Yahoo Web Search

Sign In

Search results

  1. www.ncbi.nlm.nih.gov › pmc › articlesIARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to...

    Feb 24, 2015 · The IARC Monographs on the Evaluation of Carcinogenic Risks to Humans of the International Agency for Research on Cancer (IARC) are a prominent example of such an expert review process. The goal of the Monograph Programme is to assess carcinogenic hazards from occupational, environmental, and lifestyle exposures and agents, thus providing an ...

    • Neil Pearce, Aaron Blair, Paolo Vineis, Wolfgang Ahrens, Aage Andersen, Josep M. Anto, Bruce K. Arms...
    • 2015

  2. monographs.iarc.who.int › home › iarc-monographsIARC Monographs – General Information – IARC Monographs on ...

    The principles, procedures, and scientific criteria that guide the evaluations are described in the Preamble to the IARC Monographs. Since 1971, more than 1000 agents have been evaluated, of which more than 500 have been identified as carcinogenic, probably carcinogenic, or possibly carcinogenic to humans.

  3. People also ask

  4. www.iarc.who.int › infographics › iarc-monographsIARC Monographs hazard classification – IARC

    Jun 16, 2023 · IARC Monographs. hazard classification. This infographic presents the categories used by the IARC Monographs on the Identification of Carcinogenic Hazards to Humans to classify a substance according to the level of certainty that the substance can cause cancer. This classification does not indicate the level of risk associated with exposure. View.

  5. www.ncbi.nlm.nih.gov › books › NBK570329Analysis of key characteristics of human carcinogens

    Since its establishment in the early 1970s, the IARC Monographs Programme has evaluated more than 1000 agents with evidence of human exposure and for which some suspicion exists of an increased cancer risk to humans. The IARC Monographs Programme has developed detailed criteria against which to evaluate the available scientific evidence on the carcinogenic potential of such agents. These ...

    • Daniel Krewski, Mustafa Al-Zoughool, Michael Bird, Nicholas Birkett, Mélissa Billard, Brittany Milto...
    • 2019
    • 2019

  6. www.ncbi.nlm.nih.gov › pmc › articlesThe IARC Monographs: Updated Procedures for Modern and ...

    Sep 9, 2019 · The agent is carcinogenic to humans (group 1): This category is used whenever there is sufficient evidence of carcinogenicity in humans. In addition, this category may apply when there is both strong evidence in exposed humans that the agent exhibits key characteristics of carcinogens and sufficient evidence of carcinogenicity in experimental ...

    • Jonathan M Samet, Weihsueh A Chiu, Vincent Cogliano, Jennifer Jinot, David Kriebel, Ruth M Lunn, Fre...
    • 2020

  7. www.cancer.org › cancer › risk-preventionDetermining if Something Is a Carcinogen | American Cancer ...

    Substances and exposures that can lead to cancer are called carcinogens. In general, the American Cancer Society does not determine if something causes cancer (that is, if it is a carcinogen ), but we do look to other respected organizations for help with this. When a substance or exposure has been labeled a carcinogen, it means it has been ...

  8. monographs.iarc.who.int › agents-classified-by-theAgents Classified by the IARC Monographs, Volumes 1–135

    Dec 1, 2023 · Read the IARC Monographs Q&A for answers to commonly asked questions on the evaluation process. Note: In September 2022, four additional individual Group 1 agents were created by splitting up some existing agent groupings because not all agents in the groups had the same cancer sites with sufficient and limited evidence for cancer in humans.